Mersana Therapeutics Inc (NAS:MRSN)
$ 2.37 0.07 (3.04%) Market Cap: 292.77 Mil Enterprise Value: 160.46 Mil PE Ratio: 0 PB Ratio: 237.00 GF Score: 29/100

Mersana Therapeutics, Inc. - Special Call Transcript

Jan 05, 2021 / 03:00PM GMT
Release Date Price: $18.7 (-29.49%)
Operator

Good morning and welcome to Mersana Therapeutics 2021 Virtual Analyst and Investor Day. (Operator Instructions)

I would like now to turn the call over to Sarah Carmody, Executive Director, Investor Relations and Corporate Communications. Please proceed.

Sarah Carmody
Mersana Therapeutics, Inc. - Executive Director of IR & Corporate Communications

Good morning, and welcome to our first-ever analyst and investor day event. This morning, we issued a press release providing an update on XMT-1536 as well as our goals and anticipated milestones for 2021. Through -- this release as well as the slides we will present today are available on the Investors and Media section of our website at www.mersana.com. A replay of today's call will also be made available. After our prepared remarks, we will open the call for Q&A. Please note that there is a dial-in phone number for investors and analysts who plan to ask the question that was provided this morning in the press release.

Before

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot